Central African Republic vs Gabon: The number of people with susceptibility test result for rifampicin
Central African Republic
660
in 2021
Gabon
807
in 2021
Central African Republic rank
73rd
Gabon rank
70th
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Gabon
How they compare
Gabon currently reports 807 against 660 in Central African Republic, a difference of 147.
That makes Gabon's figure about 1.2 times Central African Republic's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Gabon ahead.
Central African Republic ranks 73rd and Gabon ranks 70th of 155 countries.
Gabon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 101.67 | 1,104 | 1,002 | Gabon |
| 2020s | 665.5 | 722 | 56.5 | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Gabon?
- Gabon, at 807 against 660 in Central African Republic as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Gabon?
- 147, with Gabon ahead.
- How many years of comparable data are there for Central African Republic and Gabon?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Gabon rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 73rd and Gabon ranks 70th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.